Sample size calculation for CEP study [Power / Sample Size]

posted by GM – India, 2018-07-25 13:52 (790 d 20:51 ago) – Posting: # 19099
Views: 1,338

Hello All,

I have very limited knowledge on Sample size calculation for Clinical Endpoint study.

I was serched for the same in this forum. Bt I didn't get clear idea on calculation of sample size.

I have the blow information to calculate Sample size.

Study Title: "RANDOMIZED, PLACEBO CONTROLLED, PARALLEL-GROUP STUDY, COMPARING TEST Vs. RLD"

RLD appears to produce a percent reduction for IL that could be as low as 55.8% and vehicle %reduction can be as high as 41.5% after 12 weeks of treatment.

For NIL, the %reduction for RLD appears to be approximately 43.5% with vehicle producing as high as 27.9% reduction.

The anticipated standard deviation for IL and NIL is 36% for active treatment and 45% for vehicle treatment.


The sample size should sufficient to show superiority b/w Test, RLD Vs. Vehicle and equivalence b/w Test Vs. RLD.

My doubt is, whether we need to calculate seperate sample size for superiority and equivalence or at the same time.

Any SAS code or R code availabe for the same. Kindly suggest something on this.

Thanks in advance,
Regards,
GM.

Best Regards,
GM

Complete thread:

Activity
 Admin contact
21,071 posts in 4,393 threads, 1,466 registered users;
online 3 (0 registered, 3 guests [including 1 identified bots]).
Forum time: Wednesday 10:44 CEST (Europe/Vienna)

The important thing in science is not so much to obtain new facts
as to discover new ways of thinking about them.    William Henry Bragg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5